Key Highlights

  • Tissue Repair has resumed direct distribution and management of TR Pro+ in the aesthetic channel in Australia and New Zealand, alongside its medical channel distribution.
  • Advanced Cosmeceuticals had been the distributor for those aesthetic markets since September 2025.
  • The company does not currently anticipate any interruption to customers' ability to order, and the release gives no financial information.

Tissue Repair Limited (ASX:TRP) announced on 2 September 2026 that it has resumed direct distribution and management of TR Pro+ in the aesthetic channel in Australia and New Zealand. It already distributes the product directly in the medical channel.

The change in distribution model

Advanced Cosmeceuticals Pty Ltd was appointed as Tissue Repair's distributor for TR Pro+ in the Australian and New Zealand aesthetic markets in September 2025, so the arrangement lasted roughly a year. The company says it has determined that returning to a direct distribution model is appropriate for the next stage of development of the TR Pro+ business. The release does not explain why the earlier arrangement ended or whether any payments are involved.

Transition steps

Tissue Repair is taking steps to transition customer relationships, ordering and account management to itself. It will assume direct responsibility for customer relationships, sales, ordering and account management, as well as customer engagement related to Business development opportunities, promotions and education.

Continuity for customers

The company says it is focused on continuity of Supply and customer support during the transition and does not currently anticipate any interruption to customers' ability to order TR Pro+. This reflects its current expectation, and the release does not describe contingency arrangements.

About TR Pro+

TR Pro+ is Tissue Repair's proprietary hydrogel, designed for use following aesthetic procedures and in the management of acute wounds. It is listed on the Australian Register of Therapeutic Goods. The company says it will provide further updates on the transition and on development of the TR Pro+ business as appropriate, and the announcement was authorised by the Board. The release gives no sales figures, Margin impact or cost of resuming direct distribution.

Distribution history and current channels

Tissue Repair now manages TR Pro+ directly in both the aesthetic and medical channels in Australia and New Zealand. The aesthetic channel had been handled by a distributor for about a year. The company says it will take direct responsibility for sales, ordering, account management and customer engagement, including promotions and education, and will provide further updates on the transition as appropriate.

What is not disclosed

The announcement does not say how much TR Pro+ Revenue comes from the aesthetic channel, what the transition will cost, or whether Tissue Repair will add sales staff. It also does not explain the terms on which the distribution arrangement with Advanced Cosmeceuticals ended.